Sullivan & Worcester LLP’s US venture capital and emerging companies practice forms a key part of its international offering, with the team distinguished by its ability to lean on platforms in global start-up hubs such as London and Tel Aviv. From the US, it also maintains longstanding relationships with start-ups and funds in the Nordic region. From New York, Scott Kaufman co-heads the group and brings to bear niche expertise in representing Israeli and other international high-tech entities in US-based work. Lewis Segall leads the corporate department in Boston, where he is engaged by high-growth companies and investors to handle financings, M&A, and securities-related matters.
Legal 500 Editorial commentary

Key clients

  • Datanon Corporation
  • Alarum Technologies Ltd.
  • RedHill Biopharma Ltd.
  • PolyPid Ltd.
  • BiomX Inc.
  • Biomica Ltd.
  • 97212 Studio/97212 Management
  • Alliance Global Partners
  • Concorde Health
  • DarioHealth

Work highlights

Advised Arbol on capital raises, corporate acquisitions, employment issues, various commodities laws, and other regulatory issues.
Advised DarioHealth Corp on its acquisition of Twill.
Advised Rescue Hearing on licensing, strategic collaborations, and asset sales.

Lawyers

Practice head

Scott Kaufman; Lewis Segall

Other key lawyers

Ben Armour; Michael Student